期刊文献+

血清脂联素、尿酸、同型半胱氨酸在帕金森病中的变化及意义 被引量:1

Changes and significance of serum adiponectin, uric acid and homocysteine in patients with Parkinson’s disease
原文传递
导出
摘要 目的 探讨血清脂联素、尿酸、同型半胱氨酸在帕金森病(PD)中的变化及意义。方法 选择2021年1月—2022年4月本院收治的73例PD患者作为研究对象,另外选择同期体检的健康人群作为健康组,收集并对比2组研究对象一般资料和血清学指标,采用logistic回归分析影响PD发病风险的因素,采用ROC曲线分析APN、UA、Hcy预测PD风险的价值,对比不同H-Y分期患者的血清学指标,并采用Spearman方法分析APN、UA、Hcy与H-Y分期的关系。结果 PD组患者UA、APN、SOD水平低于健康组(P<0.05),Hcy、Cys-C水平高于健康组(P<0.05);logistic回归分析显示,APN、UA、Hcy是PD发病的主要影响因素(P<0.05),Cys-C、SOD与PD的发生无相关性(P>0.05);ROC曲线分析结果显示,APN、UA、Hcy预测PD发病风险的AUC分别为0.784、0.764、0.833;PD患者APN、UA与H-Y分期成负相关(P<0.05),Hcy与H-Y分期成正相关(P<0.05)。结论 APN、UA、Hcy与PD发病风险和病情程度紧密相关,在预测PD发病风险和评估病情方面有潜在应用价值。 Objective This paper aims to investigate the changes and significance of serum adiponectin, uric acid and homocysteine in patients with Parkinson’s disease(PD). Methods A total of 73 PD patients admitted to our hospital from January 2021 to April 2022 were selected as the study subjects, and healthy people who underwent physical examination during the same period were selected as the health group. General data and serological indexes of subjects were collected and compared between the two groups, the factors influencing the PD risk were analyzed by logistic regression, and the value of APN, UA and Hcy in predicting the PD risk was analyzed by ROC curve. The serological indexes of patients with different H-Y stages were compared, and the relationship between APN, UA, Hcy and H-Y stage was analyzed by Spearman method. Results The levels of UA, APN and SOD in PD group were lower than those in healthy group(P<0.05), the levels of Hcy and Cys-C were higher than those in healthy group(P<0.05). Logistic regression analysis showed that APN, UA and Hcy were the main influencing factors of PD(P<0.05), and there was no significant correlation between Cys-C, SOD and PD(P<0.05). ROC curve analysis showed that the AUC of APN, UA and Hcy in predicting the PD risk was 0.784, 0.764 and 0.833, respectively. APN and UA were negatively correlated with H-Y stage in PD patients(P<0.05), and Hcy was positively correlated with H-Y stage(P<0.05). Conclusion APN, UA and Hcy are closely related to the PD risk and severity, and have potential application value in predicting the PD risk and evaluating the disease.
作者 陈志裕 楼敏芳 胡宁 汪翔 CHEN Zhi-yu;LOU Min-fang;HU Ning;WANG Xiang(Department of Neurology,Quzhou Hospital of Traditional Chinese Medicine,Zhejiang 324002,China)
出处 《中国卫生检验杂志》 CAS 2023年第5期564-567,共4页 Chinese Journal of Health Laboratory Technology
基金 浙江省医药卫生科技计划项目(2022521334)。
关键词 帕金森病 脂联素 尿酸 同型半胱氨酸 Hoehn-Yahr分期 Parkinson’s disease Adiponectin Uric acid Homocysteine Hoehn-Yahr staging
  • 相关文献

参考文献17

二级参考文献156

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 2Chinta SJ,Andersen JK. Redox imbalance in Parkinson's disease [J]. Biochim Biophys Acta, 2008, 1780(11): 1362-1367.
  • 3Blum D,Torch S, Lambeng N, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA,dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease [J]. Prog Neurobiol,2001, 65 (2): 135-172.
  • 4Schapira AH .Mitochondria in theaetiology and pathogenesis of Parkinson's disease[J]. Lancet Neurol, 2008, 7(1): 97-109.
  • 5Greene JC, Whitworth AJ, Kuo I, et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants [J]. Proc Natl Acad Sci U S A, 2003, 100(7): 4078-4083.
  • 6Ritz B, Rhodes SL, Qian L, et al. L-Type Calcium Channel Blockers and Parkinson Disease in Denmark[J]. Ann Neurol, 2010, 67(5): 600- 606.
  • 7Madenci G, Bilen S, Arli B, et al. Serum Iron,Vitamin B12 and Folic Acid Levels in Parkinson's Disease [J]. Neuroehem Res, 2012, 37(7): 1436-1441.
  • 8Phani S, Loike JD, Przedborski S. Neurodegeneration and Inflamma- tion in Parkinson's disease [J]. Parkinsonism Relat Disord, 2012, 18: 207-209.
  • 9Venkateshappa C, Harish G, Mythri RB, et al. Increased Oxidative Damage and Decreased Antioxidant Function in Aging Human Substantia Nigra Compared to Striatum:Implications for Parkinson's Disease[J]. Neurochem Res, 2012, 37(2): 358-369.
  • 10Palhagen S, Heinonen E, Hagglund J, et al. Selegiline slows the progression of the symptoms of Parkinson disease [J]. Neurology, 2006, 66(8): 1200-1206.

共引文献203

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部